[Role of adrenergic receptors in the regulation of metabolism of macroenergetic cardiac phosphates. II. Effect of adrenalinemia and alpha- and beta-adrenolytic agents].
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology*; D004878:Ergotamine / Q000494:pharmacology; D006352:Heart Ventricles / Q000032:analysis; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D011433:Propranolol; D004878:Ergotamine; D004837:Epinephrine
Rola receptora adrenergicznego w regulacji metabolizmu makroenergetycznych fosforanów serca. II. Wpływ adrenalinemii na tle działania środków alfa i beta-adrenolitycznych.